Women who have not been infected with HBV can safely receive the hepatitis B vaccine during pregnancy.12,13 In addition to the standard vaccination procedure, the accelerated vaccination schedule (0, 1, and 2 months) has been proven to be feasible and efficacious.14 Accidentally-exposed people ...
Despite the availability of a vaccine, hepatitis B virus (HBV) infection is endemic, estimated to affect 400 million people worldwide, with very high hepatitis B surface antigen (HBsAg) carriage rates (up to 20%) particularly in south and east Asia. High carriage rates (up to 10%) are ...
Whether vaccine should be boosted in infants born to HBsAg(+) mothers is unclear. Systematic review also showed that the response to vaccine is similar between infants born to HBsAg(+) mothers and the general population.21While the titer of anti-hepatitis B surface antibody should be regularly ...
Guideline Summary An estimated 400 million people worldwide are living with chronic hepatitis B virus (HBV) infection. The incidence of new cases of acute HBV infection has fallen dramatically in the United States over the past two decades, primarily as a result of the availability of immunizatio...
A large proportion of hepatitis B virus (HBV) infections occur within countries in sub-Saharan Africa. With recent increased migration from these countries to Catalonia Spain, the prevalence of HBV is greater in migrants than in host populations. However, migrants face additional barriers when trying...
Hepatitis A and hepatitis B vaccines are now widely available throughout the United States, Europe, and most of the rest of the world. A recombinant hepatitis B vaccine was licensed in the United States in 1986, followed by hepatitis A vaccine in 1995. Official recommendations from the Advisory...
In: Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention. Published May 31, 2018. Accessed October 22, 2020. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt04-hepb.html 19. Chou R, Blazina I, Bougatsos C, et al. Screening...
South African guideline for the management of chronic hepatitis B: 2013 Hepatitis B remains a significant yet preventable health issue in South Africa. The introduction of the hepatitis B vaccine into the country some 18 years ... CWN Spearman,MW Sonderup,JF Botha,... - 《South African Medic...
Ott JJ, Stevens GA, Groeger J et al (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212–2219 Article CAS PubMed Google Scholar Panduro A, Maldonado-Gonzalez M, Fierro NA et al (2013) Distribution of...
In this study, the most difficult to interpret findings concerned the “side effect” of acceptance of the hepatitis B vaccine. After repeat interviews with the families of several patients, we discovered that in addition to concern about the vaccine quality and price, social discrimination played ...